DERAZANTINIB
UNII N9B0H171MJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Derazantinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N9B0H171MJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1234356-69-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N9B0H171MJ

CAS Registry Number

1234356-69-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DERAZANTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H29FN4O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KPJDVVCDVBFRMU-AREMUKBSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C104267

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

46834118

Unique identification number in the NCBI database of chemical substances.

INN ID

10488

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-224

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c(ncc2C[C@H](c3c(-c12)cccc3)c4c(cccc4)F)Nc5cc(ccc5)CCNCCOC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Derazantinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.